Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06360120 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 5, 2025 (before its estimated September 10, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Apr 10, 2025 to Sep 10, 2025v2 Show 5 more changesShow less
    • Study completion date: May 10, 2025 to Oct 1, 2025
    • Interventions: Atorvastatin 40 Mg Oral Tablet (Drug), Rosuvastatin 20mg (Drug) to Atorvastatin 40 Mg Oral Tablet (Drug), Clopidogrel 75 Mg Oral Tablet (Drug), Clopidogrel 75 Mg Oral Tablet (Drug), Rosuvastatin 20mg (Drug)
    • Secondary endpoints: 6 to 5
    • Study description shortened, about 28 words
    • Eligibility criteria expanded, about 4 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Kafrelsheikh University
152 trials monitored
See 1 trial at risk
Stroke
3,531 trials monitored
See 153 trials at risk
Along with the current clinical trial, the impact of adding atorvastatin or rosuvastatin in the first 24 hours on the clinical outcomes of first-ever large-vessel ischemic stroke patients treated with clopidogrel assessed through NIHSS, mRS, and possible adverse effects.
Trial Details
NCT Number NCT06360120
Lead Sponsor Kafrelsheikh University
Conditions
(from sponsor)		 Ischemic Stroke
Related terms Ischemic Stroke, Stroke
Enrollment 600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov